Drugs / Exosomes
Exosomes
Trials 10
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 03 trials | ||||||
| Phase 0 | NCT07665619 | Jul 2026 → Dec 2027 expected | radiation cystitis | Fujian Medical University Union Hospital | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT07635459 | Jul 2026 → Jun 2027 expected | chronic rhinosinusitis | The First Affiliated Hospital of Xinxiang Medical College | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT06932393 | Apr 2025 → Apr 2026 | alopecia | Guangzhou Bio-gene Technology Co., Ltd | Terminated | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT07295067 | Dec 2025 → May 2026 overdue | syringomyelia | Xuanwu Hospital, Beijing | Active not recruiting | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT07467733 | Jun 2026 → Jun 2028 expected | cerebellar ataxia | Biocells Medical | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT06764004 | Jan → Feb 2025 overdue | periodontitis | TC Erciyes University | Not yet recruiting | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT07838454 | Dec 2026 → May 2027 expected | Sjogren syndrome | Banu Erkal | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07382453 | Feb 2026 → Dec 2028 expected | keratopathy | Affiliated Hospital of Nantong University | Not yet recruiting | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07372001 | Jul → Dec 2024 | skin atrophy | Instituto de Oftalmología Fundación Conde de Valenciana | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07565844 | Feb 2025 → Aug 2026 overdue | postherpetic neuralgia | Zagazig University | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07868445 Comparator | Jun → Sep 2025 | skin atrophy | October 6 University | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Exosomes | “Intranasal infusion of purified exosomes derived from mesenchymal stem cells” NCT07467733 ↗10“Human umbilical cord stem cells and exosomes will be used.” NCT06764004 ↗ |
| Known as | hUC-MSC-Exo | “human umbilical cord mesenchymal stem cell-derived exosomes (hUC-MSC-Exo)” NCT07665619 ↗ |
| Known as | hUC-MSC-sEV | “Intrathecal injection human umbilical cord-derived mesenchymal stromal cell-derived extracellular vesicle (hUC-MSC-sEV) in syringomyelia” NCT07295067 ↗ |
| Action | Restore | “the use of stem cell-derived exosomes in regenerative therapies could be a promising regenerative tool for dentin-pulp complex regeneration.” NCT06764004 ↗ |
| Modality | Other / unclassified | “Exosomes are extracellular vesicles with different sizes ranging from 30-200 nm in diameter.” NCT06764004 ↗ |
| Route | Other | “placement of exosomes from umbilical cord-derived MSCs into the root canals without causing bleeding in the periapical region” NCT06764004 ↗ |